Taplitumomab paptox | m-entrepreneurship.com

Product Name :
Taplitumomab paptox

Search keywords :
Taplitumomab paptox

drugId :
null

Target Vo:
B-lymphocyte antigen CD19

Target Vo Short Name :
CD19

Moa_Name:
B-lymphocyte antigen CD19 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Minnesota

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Leukemia

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AMPK alpha Antibody
MEK1/2 Antibody
Beta-Catenin Antibody: Beta-Catenin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to Beta-Catenin. It can be used for WB,IHC-P,IF,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts